Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/95024
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Campo DC Valor Lengua/Idioma
dc.contributor.authorTorina, Alessandra-
dc.contributor.authorMoreno-Cid, Juan A.-
dc.contributor.authorFernández de Mera, Isabel G.-
dc.contributor.authorPérez de Lastra, José Manuel-
dc.contributor.authorVicente, Joaquín-
dc.contributor.authorGortázar, Christian-
dc.contributor.authorFuente, José de la-
dc.date.accessioned2014-04-05T07:31:35Z-
dc.date.available2014-04-05T07:31:35Z-
dc.date.issued2014-01-08-
dc.identifier.citationParasites and Vectors 7: 10 (2014)-
dc.identifier.issn1756-3305-
dc.identifier.urihttp://hdl.handle.net/10261/95024-
dc.descriptionThis is an Open Access article distributed under the terms of the Creative Commons Attribution License.-- et al.-
dc.description.abstract[Background]: Despite the use of chemical acaricides, tick infestations continue to affect animal health and production worldwide. Tick vaccines have been proposed as a cost-effective and environmentally friendly alternative for tick control. Vaccination with the candidate tick protective antigen, Subolesin (SUB), has been shown experimentally to be effective in controlling vector infestations and pathogen infection. Furthermore, Escherichia coli membranes containing the chimeric antigen composed of SUB fused to Anaplasma marginale Major Surface Protein 1a (MSP1a) (SUB-MSP1a) were produced using a simple low-cost process and proved to be effective for the control of cattle tick, Rhipicephalus (Boophilus) microplus and R. annulatus infestations in pen trials. In this research, field trials were conducted to characterize the effect of vaccination with SUB-MSP1a on tick infestations and the prevalence of tick-borne pathogens in a randomized controlled prospective study. [Methods]: Two cattle and two sheep farms with similar geographical locations and production characteristics were randomly assigned to control and vaccinated groups. Ticks were collected, counted, weighed and classified and the prevalence of tick-borne pathogens at the DNA and serological levels were followed for one year prior to and 9 months after vaccination. [Results]: Both cattle and sheep developed antibodies against SUB in response to vaccination. The main effect of the vaccine in cattle was the 8-fold reduction in the percent of infested animals while vaccination in sheep reduced tick infestations by 63%. Female tick weight was 32-55% lower in ticks collected from both vaccinated cattle and sheep when compared to controls. The seroprevalence of Babesia bigemina was lower by 30% in vaccinated cattle, suggesting a possible role for the vaccine in decreasing the prevalence of this tick-borne pathogen. The effect of the vaccine in reducing the frequency of one A. marginale msp4 genotype probably reflected the reduction in the prevalence of a tick-transmitted strain as a result of the reduction in the percent of tick-infested cattle. [Conclusions]: These data provide evidence of the dual effect of a SUB-based vaccine for controlling tick infestations and pathogen infection/transmission and provide additional support for the use of the SUB-MSP1a vaccine for tick control in cattle and sheep.-
dc.description.sponsorshipThis research was supported by the Italian Ministry of Health IZS, project SI09/09 and BFU2011-23896 grant to JF. J.A. Moreno-Cid was funded by the Consejería de Educación y Ciencia, JCCM, Spain (project PEII09-0118-8907) as a recipient of a JCCM fellowship.-
dc.publisherBioMed Central-
dc.relation.isversionofPublisher's version-
dc.rightsopenAccess-
dc.titleControl of tick infestations and pathogen prevalence in cattle and sheep farms vaccinated with the recombinant Subolesin-Major Surface Protein 1a chimeric antigen-
dc.typeartículo-
dc.identifier.doi10.1186/1756-3305-7-10-
dc.relation.publisherversionhttp://dx.doi.org/10.1186/1756-3305-7-10-
dc.date.updated2014-04-05T07:31:35Z-
dc.description.versionPeer Reviewed-
dc.language.rfc3066en-
dc.rights.licensehttp://creativecommons.org/licenses/by/2.0-
dc.contributor.funderMinistero della Salute-
dc.contributor.funderJunta de Comunidades de Castilla-La Mancha-
dc.identifier.funderhttp://dx.doi.org/10.13039/501100003196es_ES
dc.identifier.funderhttp://dx.doi.org/10.13039/501100011698es_ES
dc.identifier.pmid24398155-
dc.type.coarhttp://purl.org/coar/resource_type/c_6501es_ES
item.grantfulltextopen-
item.openairetypeartículo-
item.cerifentitytypePublications-
item.fulltextWith Fulltext-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
Aparece en las colecciones: (IREC) Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato
1756-3305-7-10.xml83,13 kBXMLVisualizar/Abrir
1756-3305-7-10.pdf2,17 MBAdobe PDFVista previa
Visualizar/Abrir
1756-3305-7-10-S1.PDF471,81 kBAdobe PDFVista previa
Visualizar/Abrir
Show simple item record

CORE Recommender

PubMed Central
Citations

13
checked on 13-may-2024

SCOPUSTM   
Citations

35
checked on 10-may-2024

WEB OF SCIENCETM
Citations

33
checked on 28-feb-2024

Page view(s)

407
checked on 14-may-2024

Download(s)

520
checked on 14-may-2024

Google ScholarTM

Check

Altmetric

Altmetric


Artículos relacionados:


Este item está licenciado bajo una Licencia Creative Commons Creative Commons